Mercè Boada, MD, PhD
Mercè Boada, MD, PhD
Neuróloga. MD, PhD
Dirección de correo verificada de fundacioace.com
TítuloCitado porAño
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ...
Nature genetics 45 (12), 1452, 2013
18812013
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo, S Gilman, JF Dartigues, B Laurent, M Puel, LC Kirby, ...
Neurology 61 (1), 46-54, 2003
14812003
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman, M Koller, RS Black, L Jenkins, SG Griffith, NC Fox, L Eisner, ...
Neurology 64 (9), 1553-1562, 2005
12892005
Genome-wide analysis of genetic loci associated with Alzheimer disease
S Seshadri, AL Fitzpatrick, MA Ikram, AL DeStefano, V Gudnason, ...
Jama 303 (18), 1832-1840, 2010
10352010
Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
NC Fox, RS Black, S Gilman, MN Rossor, SG Griffith, L Jenkins, M Koller
Neurology 64 (9), 1563-1572, 2005
5322005
Analysis of shared heritability in common disorders of the brain
V Anttila, B Bulik-Sullivan, HK Finucane, RK Walters, J Bras, L Duncan, ...
Science 360 (6395), eaap8757, 2018
2722018
Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke
DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ...
American journal of preventive medicine 20 (2), 16-66, 2001
2702001
A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer’s disease
L Tárraga, M Boada, G Modinos, A Espinosa, S Diego, A Morera, ...
Journal of Neurology, Neurosurgery & Psychiatry 77 (10), 1116-1121, 2006
2412006
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373, 2017
2242017
Trial of solanezumab for mild dementia due to Alzheimer’s disease
LS Honig, B Vellas, M Woodward, M Boada, R Bullock, M Borrie, K Hager, ...
New England Journal of Medicine 378 (4), 321-330, 2018
1742018
Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP
RJ Guerreiro, M Baquero, R Blesa, M Boada, JM Brás, MJ Bullido, ...
Neurobiology of aging 31 (5), 725-731, 2010
1682010
A phase II trial of tideglusib in Alzheimer's disease
S Lovestone, M Boada, B Dubois, M Hüll, JO Rinne, HJ Huppertz, ...
Journal of Alzheimer's Disease 45 (1), 75-88, 2015
1632015
Frontotemporal dementia and its subtypes: a genome-wide association study
R Ferrari, DG Hernandez, MA Nalls, JD Rohrer, A Ramasamy, JBJ Kwok, ...
The Lancet Neurology 13 (7), 686-699, 2014
1552014
Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies
LA Rabin, CM Smart, PK Crane, RE Amariglio, LM Berman, M Boada, ...
Journal of Alzheimer's Disease 48 (s1), S63-S86, 2015
1472015
A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy
E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ...
Movement Disorders 29 (4), 470-478, 2014
1352014
A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved
A Espinosa, M Alegret, S Valero, G Vinyes-Junqué, I Hernández, ...
Journal of Alzheimer's Disease 34 (3), 769-780, 2013
1152013
A novel Alzheimer disease locus located near the gene encoding tau protein
G Jun, CA Ibrahim-Verbaas, M Vronskaya, JC Lambert, J Chung, AC Naj, ...
Molecular psychiatry 21 (1), 108, 2016
1052016
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
R Vandenberghe, JO Rinne, M Boada, S Katayama, P Scheltens, B Vellas, ...
Alzheimer's research & therapy 8 (1), 18, 2016
912016
Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease
M Balasa, E Gelpi, A Antonell, MJ Rey, R Sanchez-Valle, JL Molinuevo, ...
Neurology 76 (20), 1720-1725, 2011
902011
Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
GU Höglinger, HJ Huppertz, S Wagenpfeil, MV Andrés, V Belloch, T León, ...
Movement Disorders 29 (4), 479-487, 2014
852014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20